Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

OBJECTIVE: When oral therapy for type 2 diabetes is ineffective, adding basal insulin improves glycemic control. However, when glycated hemoglobin (HbA(1c)) remains elevated because of postprandial hyperglycemia, the next therapeutic step is controversial. We examined the efficacy and safety of lixi...

Descripción completa

Detalles Bibliográficos
Autores principales: Riddle, Matthew C., Forst, Thomas, Aronson, Ronnie, Sauque-Reyna, Leobardo, Souhami, Elisabeth, Silvestre, Louise, Ping, Lin, Rosenstock, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747901/
https://www.ncbi.nlm.nih.gov/pubmed/23564915
http://dx.doi.org/10.2337/dc12-2462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747901/
https://www.ncbi.nlm.nih.gov/pubmed/23564915
http://dx.doi.org/10.2337/dc12-2462

Ejemplares similares